Atenolol
- Product NDC
- 0615-8026
- 11-digit product format
- 006158026
- Labeler code
- 0615
- Product ID
- 0615-8026_e3f0cfd2-cf6f-4676-9730-d5c23d49e853
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atenolol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA074056
- Marketing category
- ANDA
- Marketing start
- 2004-11-16
- Marketing end
- 2022-08-31
- Substance
- ATENOLOL
- Active strength
- 25 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0615-8026-05 | 00615802605 | 15 TABLET in 1 BLISTER PACK (0615-8026-05) | 15 tablet | 2016-05-16 | 2022-08-31 | No | No | Current |
| 0615-8026-30 | 00615802630 | 6 BLISTER PACK in 1 BOX, UNIT-DOSE (0615-8026-30) > 5 TABLET in 1 BLISTER PACK | 6 blister pack | 2016-06-09 | 2022-04-30 | No | No | Current |
| 0615-8026-39 | 00615802639 | 30 TABLET in 1 BLISTER PACK (0615-8026-39) | 30 tablet | 2016-05-16 | 2022-08-31 | No | No | Current |